ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat breast cancer: targeted drug enters final testing
Disease control OngoingThis study is comparing a new targeted drug called trastuzumab deruxtecan against standard chemotherapy for people with advanced breast cancer that has a specific low level of the HER2 protein and has stopped responding to hormone therapy. It aims to see if the new drug helps pat…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 02, 2026 07:27 UTC
-
New hope for advanced breast cancer patients after standard treatment fails
Disease control OngoingThis study is testing whether adding an experimental drug called PF-07220060 to the standard hormone therapy fulvestrant works better than current treatment options for people with advanced breast cancer. It's for adults whose cancer has continued to grow despite previous treatme…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC